People_

Associate Professor David van der Poorten

Clinical Senior Lecturer
Medicine, Westmead Clinical School, Staff Specialist Gastroenterology and Hepatology

Phone

+61 2 87110160

Fax

+61 2 86244769

Email

david.vanderpoorten@sydney.edu.au

Websites

Website SNWG

Publications

By Type

Expand all

Book Chapters

van der Poorten, D., Milner, K., George, J. (2009). Effect of adipokines on liver disease in females. In Ichiro Shimizu (Eds.), Female Hepatology: Impact of female sex against progression of liver disease, (pp. 191-212). India: Research Signpost.

Journals

Emerson, J., van der Poorten, D., Lin, M., Chou, S., McLeod, D., Berglund, L. (2021). Duodenal plasma cells correspond to serum IgA in common variable immunodeficiency. Pathology, 53(4), 503-507. [More Information]
Wijaya, R., Read, S., Schibeci, S., Han, S., Azardaryany, M., van der Poorten, D., Lin, R., Yuen, L., Lam, V., Douglas, M., George, J., Ahlenstiel, G. (2021). Expansion of dysfunctional CD56-CD16+ NK cells in chronic hepatitis B patients. Liver International, 41(5), 969-981. [More Information]
Wijaya, R., Read, S., Truong, N., Han, S., Chen, D., Shahidipour, H., Fewings, N., Schibeci, S., Azardaryany, M., Parnell, G., Booth, D., van der Poorten, D., Lin, R., George, J., Douglas, M., Ahlenstiel, G. (2021). HBV vaccination and HBV infection induces HBV-specific natural killer cell memory. Gut, 70(2), 357-369. [More Information]
Wijaya, R., Read, S., Selvamani, S., Schibeci, S., Azardaryany, M., Ong, A., van der Poorten, D., Lin, R., Douglas, M., George, J., Ahlenstiel, G. (2021). Hepatitis C Virus (HCV) Eradication With Interferon-Free Direct-Acting Antiviral-Based Therapy Results in KLRG1+ HCV-Specific Memory Natural Killer Cells. The Journal of Infectious Diseases, 223(7), 1183-1195. [More Information]
Trieu, R., van der Poorten, D. (2021). The gut microbiome in health and illness. Medicine Today, 22(3), 44-50.
Yang, A., Nguyen, M., Ju, I., Brancatisano, A., Ryan, B., van der Poorten, D. (2021). Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery. Scientific Reports, 11(1), 14006. [More Information]
Haifer, C., Kelly, C., Paramsothy, S., Andresen, D., Papanicolas, L., McKew, G., Borody, T., Kamm, M., Costello, S., Andrews, J., van der Poorten, D., Leong, R., et al (2020). Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice. Gut, 69(5), 801-810. [More Information]
Jensen, C., Nielsen, S., Eslam, M., Genovese, F., Nielsen, M., Vongsuvanh, R., Uchila, R., van der Poorten, D., George, J., Karsdal, M., et al (2020). Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma – A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients. Journal of Hepatocellular Carcinoma, 7, 301-313. [More Information]
Wijaya, R., Read, S., Schibeci, S., Eslam, M., Azardaryany, M., El-Khobar, K., van der Poorten, D., Lin, R., Yuen, L., Lam, V., George, J., Douglas, M., Ahlenstiel, G. (2019). KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B. Journal of Hepatology, 71(2), 252-264. [More Information]
van der Poorten, D., McLeod, D., Ahlenstiel, G., Read, S., Kwok, A., Santhakumar, C., Bassan, M., Culican, S., Campbell, D., Wong, S., Limaye, S., Lin, M., Suan, D., Swaminathan, S., Riminton, S., et al (2018). Gastric Cancer Screening in Common Variable Immunodeficiency. Journal of Clinical Immunology, 38(7), 768-777. [More Information]
Jideh, B., Cho, T., Yuen, L., van der Poorten, D. (2018). Subacute Upper GI Bleeding Due To Infected Aortic Graft with Aorto-Duodenal Fistula. Journal of Gastrointestinal Surgery, 22(11), 1987-1988. [More Information]
Mah, X., Gupta, V., Loch, S., Ahlenstiel, G., van der Poorten, D. (2017). Compounded Levofloxacin Triple Therapy is Safe and Effective for Refractory Helicobacter pylori. International Journal of Pharmaceutical Compounding, 21(3), 248-251.
Sidhu, M., van der Poorten, D. (2017). The gut microbiome. Australian Family Physician, 46(4), 206-211.
Eslam, M., Mangia, A., Berg, T., Chan, H., Irving, W., Dore, G., Abate, M., Bugianesi, E., Adams, L., Najim, M., Weltman, M., Rahme, A., Booth, D., Liddle, C., Douglas, M., van der Poorten, D., George, J., White, R., Leung, R., et al (2016). Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes. Hepatology, 64(1), 34-46. [More Information]
Chang, F., Kwan, V., van der Poorten, D., Mahant, N., Wolfe, N., Ha, A., Griffith, J., Tsui, D., Kim, S., Fung, V. (2016). Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson's disease. Journal of Clinical Neuroscience, 25, 41-45. [More Information]
Thabet, K., Asimakopoulos, A., Shojaei, M., Romero-Gomez, M., Mangia, A., Irving, W., Berg, T., Dore, G., Gronbaek, H., Sheridan, D., Weltman, M., White, R., Douglas, M., Liddle, C., van der Poorten, D., George, J., Eslam, M., et al (2016). MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C. Nature Communications, 7, 1-8. [More Information]
Vongsuvanh, R., van der Poorten, D., Iseli, T., Strasser, S., McCaughan, G., George, J. (2016). Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma. PloS One, 11(5), 1-12. [More Information]
Ramezani-Moghadam, M., Wang, J., Ho, V., Iseli, T., Alzahrani, B., Xu, A., van der Poorten, D., Qiao, L., George, J., Hebbard, L. (2015). Adiponectin Reduces Hepatic Stellate Cell Migration by Promoting Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Secretion. Journal of Biological Chemistry, 290(9), 5533-5542. [More Information]
Berglund, L., van der Poorten, D., Caridi, G., Campagnoli, M., Minchiotti, L. (2015). Congenital analbuminaemia diagnosed in adulthood in an Australian family. Pathology, 47(5), 492-494. [More Information]
Musumba, C., Hsu, J., Ahlenstiel, G., Tutticci, N., Nanda, K., van der Poorten, D., Lee, E., Kwan, V. (2015). Feasibility and Safety of Overtubes for PEG-Tube Placement in Patients with Head and Neck Cancer. Gastroenterology Research and Practice, 2015, 1-7. [More Information]
Gupta, V., Mah, X., Garcia, M., Antonypillai, C., van der Poorten, D. (2015). Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease. World Journal of Gastroenterology, 21(37), 10621-10635. [More Information]
Garcia, M., Ahlenstiel, G., Mahajan, H., van der Poorten, D. (2015). Small bowel varices secondary to chronic superior mesenteric vein thrombosis in a patient with heterozygous Factor V Leiden mutation: a case report. Journal of Medical Case Reports, 9(1), 1-4. [More Information]
Sivagnanam, S., van der Poorten, D., Douglas, M. (2014). Hepatic lesions and eosinophilia in an urban dweller. Liver International, 34(4), 643-643. [More Information]
O'Connor, K., Parnell, G., Patrick, E., Ahlenstiel, G., Suppiah, V., van der Poorten, D., Read, S., Leung, R., Douglas, M., Yang, J., Stewart, G., Liddle, C., George, J., Booth, D. (2014). Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent. Genes and Immunity, 15(2), 88-94. [More Information]
O'Connor, K., Ahlenstiel, G., Suppiah, V., Schibeci, S., Ong, A., Leung, R., van der Poorten, D., Douglas, M., Weltman, M., Stewart, G., Liddle, C., George, J., Booth, D. (2014). IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis. Innate Immunity, 20(6), 598-605. [More Information]
van der Poorten, D., Samer, C., Ramezani-Moghadam, M., Coulter, S., Kacevska, M., Schrijnders, D., Wu, L., McLeod, D., Bugianesi, E., Komuta, M., Liddle, C., Hebbard, L., George, J., et al (2013). Hepatic Fat Loss in Advanced Nonalcoholic Steatohepatitis: Are Alterations in Serum Adiponectin the Cause? Hepatology, 57(6), 2180-2188. [More Information]
Vongsuvanh, R., van der Poorten, D., George, J. (2013). Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific. Hepatology International, 7(Suppl 2), S823-S832. [More Information]
Hashemi, S., van der Poorten, D., Barrera Martinez, F., Bandara, P., Lux, O., Kench, J., George, J. (2013). Oxidative stress is closely associated with insulin resistance in genotypes 1 and 3 chronic hepatitis C. Hepatology International, 7(2), 516-523. [More Information]
Vongsuvanh, R., George, J., Qiao, L., van der Poorten, D. (2013). Visceral adiposity in gastrointestinal and hepatic carcinogenesis. Cancer Letters, 330(1), 1-10. [More Information]
Nguyen, V., George, J., van der Poorten, D. (2012). A maxillary mass in a HBV-cirrhotic patient. Liver International, 32(6), 988-988. [More Information]
Vongsuvanh, R., Pleass, H., van der Poorten, D. (2012). Acute necrotizing pancreatitis, gastric ischemia, and portal venous gas complicating intragastric balloon placement. Endoscopy, 44(Suppl 2), E383-E384. [More Information]
Vongsuvanh, R., George, J., McLeod, D., van der Poorten, D. (2012). Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease. Journal of Hepatology, 57(2), 392-398. [More Information]
Adams, L., George, J., Bugianesi, E., Rossi, E., de Boer, W., van der Poorten, D., Ching, H., Bulsara, M., Jeffrey, G. (2011). Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology, 26(10), 1536-1543. [More Information]
Nguyen, V., Gurney, H., van der Poorten, D. (2011). Paraneoplastic Hepatic Dysfunction in Metastatic Prostate Cancer: The Role of Cytokine Dysregulation. Journal of Clinical Oncology, 29(2), e21-e23. [More Information]
Bhala, N., Angulo, P., van der Poorten, D., Lee, E., Hui, J., Saracco, G., Adams, L., Charatcharoenwitthaya, P., Topping, J., Bugianesi, E., George, J., et al (2011). The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study. Hepatology, 54(4), 1208-1216. [More Information]
Milner, K., van der Poorten, D., Trenell, M., Jenkins, A., Xu, A., Smythe, G., Dore, G., Zekry, A., Weltman, M., Fragomeli, V., George, J., et al (2010). Chronic Hepatitis C is Associated with Peripheral rather than Hepatic Insulin Resistance. Gastroenterology, 138(3), 932-941. [More Information]
van der Poorten, D., Shahidi, M., Tay, E., Sesha, J., Tran, K., McLeod, D., Milliken, J., Ho, V., Hebbard, L., Douglas, M., George, J. (2010). Hepatitis C Virus Induces the Cannabinoid Receptor 1. PloS One, 5(9), 1-10. [More Information]
Milner, K., van der Poorten, D., Xu, A., Bugianesi, E., Kench, J., Lam, K., Chisholm, D., George, J. (2009). Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. Hepatology, 49(6), 1926-1934. [More Information]
van der Poorten, D., George, J. (2008). Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis. Clinics in Liver Disease, 12(4), 805-824. [More Information]
van der Poorten, D., George, J. (2008). Nonalcoholic steatohepatitis is frequently acompanied by metabolic diseases: Reply to the Editor. Hepatology, 48(5), 1729. [More Information]
van der Poorten, D., Kenny, D., George, J. (2008). Prevalence of and risk factors for hepatitis C in Aboriginal and non-Aboriginal adolescent offenders. Medical Journal of Australia, 188(10), 610-614. [More Information]
van der Poorten, D., Milner, K., Hui, J., Hodge, A., Trenell, M., Kench, J., London, R., Peduto, A., Chisholm, D., George, J. (2008). Visceral fat: A key mediator of steatohepatitis in metabolic liver disease. Hepatology, 48(2), 449-457. [More Information]
van der Poorten, D., Kenny, D., George, J. (2007). A new upper limit for alanine aminotransferase and risk factors for raised alt and hepatitis C in adolescents: a study of 439 male adolescent offenders on community orders. Journal of Gastroenterology and Hepatology, 22(Supplement 3), A344-A344.
van der Poorten, D., Prakoso, E., Khoo, T., Ngu, M., McCaughan, G., Strasser, S., Lee, A. (2007). Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B. Journal of Gastroenterology and Hepatology, 22(9), 1500-1505. [More Information]
van der Poorten, D., George, J. (2007). Current and novel therapies for the treatment of nonalcoholic steatohepatitis. Hepatology International, 1(3), 343-354. [More Information]
van der Poorten, D., Kenny, D., Butler, T., George, J. (2007). Liver disease in adolescents: A cohort study of high-risk individuals. Hepatology, 46(6), 1750-1758. [More Information]
van der Poorten, D., Katelaris, P. (2007). The effectiveness of rifabutin triple therapy for difficult-to-eradicate Helicobacter pylori in clinical practice. Alimentary Pharmacology and Therapeutics, 26(11), 1537-1542. [More Information]
van der Poorten, D., Kwok, A., Lam, T., Ridley, L., Jones, B., Ngu, M., Lee, A. (2006). Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital. Internal Medicine Journal, 36(11), 692-699. [More Information]

show 45 more

Conferences

van der Poorten, D., Kenny, D. (2007). Young offenders in custody and the community: Similarities and differences. 3rd International Congress of Psychology and Law, in conjunction with the 27th Annual Congress of ANZAPPL.

By Year

Expand all

2021

Emerson, J., van der Poorten, D., Lin, M., Chou, S., McLeod, D., Berglund, L. (2021). Duodenal plasma cells correspond to serum IgA in common variable immunodeficiency. Pathology, 53(4), 503-507. [More Information]
Wijaya, R., Read, S., Schibeci, S., Han, S., Azardaryany, M., van der Poorten, D., Lin, R., Yuen, L., Lam, V., Douglas, M., George, J., Ahlenstiel, G. (2021). Expansion of dysfunctional CD56-CD16+ NK cells in chronic hepatitis B patients. Liver International, 41(5), 969-981. [More Information]
Wijaya, R., Read, S., Truong, N., Han, S., Chen, D., Shahidipour, H., Fewings, N., Schibeci, S., Azardaryany, M., Parnell, G., Booth, D., van der Poorten, D., Lin, R., George, J., Douglas, M., Ahlenstiel, G. (2021). HBV vaccination and HBV infection induces HBV-specific natural killer cell memory. Gut, 70(2), 357-369. [More Information]
Wijaya, R., Read, S., Selvamani, S., Schibeci, S., Azardaryany, M., Ong, A., van der Poorten, D., Lin, R., Douglas, M., George, J., Ahlenstiel, G. (2021). Hepatitis C Virus (HCV) Eradication With Interferon-Free Direct-Acting Antiviral-Based Therapy Results in KLRG1+ HCV-Specific Memory Natural Killer Cells. The Journal of Infectious Diseases, 223(7), 1183-1195. [More Information]
Trieu, R., van der Poorten, D. (2021). The gut microbiome in health and illness. Medicine Today, 22(3), 44-50.
Yang, A., Nguyen, M., Ju, I., Brancatisano, A., Ryan, B., van der Poorten, D. (2021). Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery. Scientific Reports, 11(1), 14006. [More Information]

show 3 more

2020

Haifer, C., Kelly, C., Paramsothy, S., Andresen, D., Papanicolas, L., McKew, G., Borody, T., Kamm, M., Costello, S., Andrews, J., van der Poorten, D., Leong, R., et al (2020). Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice. Gut, 69(5), 801-810. [More Information]
Jensen, C., Nielsen, S., Eslam, M., Genovese, F., Nielsen, M., Vongsuvanh, R., Uchila, R., van der Poorten, D., George, J., Karsdal, M., et al (2020). Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma – A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients. Journal of Hepatocellular Carcinoma, 7, 301-313. [More Information]

2019

Wijaya, R., Read, S., Schibeci, S., Eslam, M., Azardaryany, M., El-Khobar, K., van der Poorten, D., Lin, R., Yuen, L., Lam, V., George, J., Douglas, M., Ahlenstiel, G. (2019). KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B. Journal of Hepatology, 71(2), 252-264. [More Information]

2018

van der Poorten, D., McLeod, D., Ahlenstiel, G., Read, S., Kwok, A., Santhakumar, C., Bassan, M., Culican, S., Campbell, D., Wong, S., Limaye, S., Lin, M., Suan, D., Swaminathan, S., Riminton, S., et al (2018). Gastric Cancer Screening in Common Variable Immunodeficiency. Journal of Clinical Immunology, 38(7), 768-777. [More Information]
Jideh, B., Cho, T., Yuen, L., van der Poorten, D. (2018). Subacute Upper GI Bleeding Due To Infected Aortic Graft with Aorto-Duodenal Fistula. Journal of Gastrointestinal Surgery, 22(11), 1987-1988. [More Information]

2017

Mah, X., Gupta, V., Loch, S., Ahlenstiel, G., van der Poorten, D. (2017). Compounded Levofloxacin Triple Therapy is Safe and Effective for Refractory Helicobacter pylori. International Journal of Pharmaceutical Compounding, 21(3), 248-251.
Sidhu, M., van der Poorten, D. (2017). The gut microbiome. Australian Family Physician, 46(4), 206-211.

2016

Eslam, M., Mangia, A., Berg, T., Chan, H., Irving, W., Dore, G., Abate, M., Bugianesi, E., Adams, L., Najim, M., Weltman, M., Rahme, A., Booth, D., Liddle, C., Douglas, M., van der Poorten, D., George, J., White, R., Leung, R., et al (2016). Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes. Hepatology, 64(1), 34-46. [More Information]
Chang, F., Kwan, V., van der Poorten, D., Mahant, N., Wolfe, N., Ha, A., Griffith, J., Tsui, D., Kim, S., Fung, V. (2016). Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson's disease. Journal of Clinical Neuroscience, 25, 41-45. [More Information]
Thabet, K., Asimakopoulos, A., Shojaei, M., Romero-Gomez, M., Mangia, A., Irving, W., Berg, T., Dore, G., Gronbaek, H., Sheridan, D., Weltman, M., White, R., Douglas, M., Liddle, C., van der Poorten, D., George, J., Eslam, M., et al (2016). MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C. Nature Communications, 7, 1-8. [More Information]
Vongsuvanh, R., van der Poorten, D., Iseli, T., Strasser, S., McCaughan, G., George, J. (2016). Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma. PloS One, 11(5), 1-12. [More Information]

show 1 more

2015

Ramezani-Moghadam, M., Wang, J., Ho, V., Iseli, T., Alzahrani, B., Xu, A., van der Poorten, D., Qiao, L., George, J., Hebbard, L. (2015). Adiponectin Reduces Hepatic Stellate Cell Migration by Promoting Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Secretion. Journal of Biological Chemistry, 290(9), 5533-5542. [More Information]
Berglund, L., van der Poorten, D., Caridi, G., Campagnoli, M., Minchiotti, L. (2015). Congenital analbuminaemia diagnosed in adulthood in an Australian family. Pathology, 47(5), 492-494. [More Information]
Musumba, C., Hsu, J., Ahlenstiel, G., Tutticci, N., Nanda, K., van der Poorten, D., Lee, E., Kwan, V. (2015). Feasibility and Safety of Overtubes for PEG-Tube Placement in Patients with Head and Neck Cancer. Gastroenterology Research and Practice, 2015, 1-7. [More Information]
Gupta, V., Mah, X., Garcia, M., Antonypillai, C., van der Poorten, D. (2015). Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease. World Journal of Gastroenterology, 21(37), 10621-10635. [More Information]
Garcia, M., Ahlenstiel, G., Mahajan, H., van der Poorten, D. (2015). Small bowel varices secondary to chronic superior mesenteric vein thrombosis in a patient with heterozygous Factor V Leiden mutation: a case report. Journal of Medical Case Reports, 9(1), 1-4. [More Information]

show 2 more

2014

Sivagnanam, S., van der Poorten, D., Douglas, M. (2014). Hepatic lesions and eosinophilia in an urban dweller. Liver International, 34(4), 643-643. [More Information]
O'Connor, K., Parnell, G., Patrick, E., Ahlenstiel, G., Suppiah, V., van der Poorten, D., Read, S., Leung, R., Douglas, M., Yang, J., Stewart, G., Liddle, C., George, J., Booth, D. (2014). Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent. Genes and Immunity, 15(2), 88-94. [More Information]
O'Connor, K., Ahlenstiel, G., Suppiah, V., Schibeci, S., Ong, A., Leung, R., van der Poorten, D., Douglas, M., Weltman, M., Stewart, G., Liddle, C., George, J., Booth, D. (2014). IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis. Innate Immunity, 20(6), 598-605. [More Information]

2013

van der Poorten, D., Samer, C., Ramezani-Moghadam, M., Coulter, S., Kacevska, M., Schrijnders, D., Wu, L., McLeod, D., Bugianesi, E., Komuta, M., Liddle, C., Hebbard, L., George, J., et al (2013). Hepatic Fat Loss in Advanced Nonalcoholic Steatohepatitis: Are Alterations in Serum Adiponectin the Cause? Hepatology, 57(6), 2180-2188. [More Information]
Vongsuvanh, R., van der Poorten, D., George, J. (2013). Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific. Hepatology International, 7(Suppl 2), S823-S832. [More Information]
Hashemi, S., van der Poorten, D., Barrera Martinez, F., Bandara, P., Lux, O., Kench, J., George, J. (2013). Oxidative stress is closely associated with insulin resistance in genotypes 1 and 3 chronic hepatitis C. Hepatology International, 7(2), 516-523. [More Information]
Vongsuvanh, R., George, J., Qiao, L., van der Poorten, D. (2013). Visceral adiposity in gastrointestinal and hepatic carcinogenesis. Cancer Letters, 330(1), 1-10. [More Information]

show 1 more

2012

Nguyen, V., George, J., van der Poorten, D. (2012). A maxillary mass in a HBV-cirrhotic patient. Liver International, 32(6), 988-988. [More Information]
Vongsuvanh, R., Pleass, H., van der Poorten, D. (2012). Acute necrotizing pancreatitis, gastric ischemia, and portal venous gas complicating intragastric balloon placement. Endoscopy, 44(Suppl 2), E383-E384. [More Information]
Vongsuvanh, R., George, J., McLeod, D., van der Poorten, D. (2012). Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease. Journal of Hepatology, 57(2), 392-398. [More Information]

2011

Adams, L., George, J., Bugianesi, E., Rossi, E., de Boer, W., van der Poorten, D., Ching, H., Bulsara, M., Jeffrey, G. (2011). Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology, 26(10), 1536-1543. [More Information]
Nguyen, V., Gurney, H., van der Poorten, D. (2011). Paraneoplastic Hepatic Dysfunction in Metastatic Prostate Cancer: The Role of Cytokine Dysregulation. Journal of Clinical Oncology, 29(2), e21-e23. [More Information]
Bhala, N., Angulo, P., van der Poorten, D., Lee, E., Hui, J., Saracco, G., Adams, L., Charatcharoenwitthaya, P., Topping, J., Bugianesi, E., George, J., et al (2011). The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study. Hepatology, 54(4), 1208-1216. [More Information]

2010

Milner, K., van der Poorten, D., Trenell, M., Jenkins, A., Xu, A., Smythe, G., Dore, G., Zekry, A., Weltman, M., Fragomeli, V., George, J., et al (2010). Chronic Hepatitis C is Associated with Peripheral rather than Hepatic Insulin Resistance. Gastroenterology, 138(3), 932-941. [More Information]
van der Poorten, D., Shahidi, M., Tay, E., Sesha, J., Tran, K., McLeod, D., Milliken, J., Ho, V., Hebbard, L., Douglas, M., George, J. (2010). Hepatitis C Virus Induces the Cannabinoid Receptor 1. PloS One, 5(9), 1-10. [More Information]

2009

Milner, K., van der Poorten, D., Xu, A., Bugianesi, E., Kench, J., Lam, K., Chisholm, D., George, J. (2009). Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. Hepatology, 49(6), 1926-1934. [More Information]
van der Poorten, D., Milner, K., George, J. (2009). Effect of adipokines on liver disease in females. In Ichiro Shimizu (Eds.), Female Hepatology: Impact of female sex against progression of liver disease, (pp. 191-212). India: Research Signpost.

2008

van der Poorten, D., George, J. (2008). Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis. Clinics in Liver Disease, 12(4), 805-824. [More Information]
van der Poorten, D., George, J. (2008). Nonalcoholic steatohepatitis is frequently acompanied by metabolic diseases: Reply to the Editor. Hepatology, 48(5), 1729. [More Information]
van der Poorten, D., Kenny, D., George, J. (2008). Prevalence of and risk factors for hepatitis C in Aboriginal and non-Aboriginal adolescent offenders. Medical Journal of Australia, 188(10), 610-614. [More Information]
van der Poorten, D., Milner, K., Hui, J., Hodge, A., Trenell, M., Kench, J., London, R., Peduto, A., Chisholm, D., George, J. (2008). Visceral fat: A key mediator of steatohepatitis in metabolic liver disease. Hepatology, 48(2), 449-457. [More Information]

show 1 more

2007

van der Poorten, D., Kenny, D., George, J. (2007). A new upper limit for alanine aminotransferase and risk factors for raised alt and hepatitis C in adolescents: a study of 439 male adolescent offenders on community orders. Journal of Gastroenterology and Hepatology, 22(Supplement 3), A344-A344.
van der Poorten, D., Prakoso, E., Khoo, T., Ngu, M., McCaughan, G., Strasser, S., Lee, A. (2007). Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B. Journal of Gastroenterology and Hepatology, 22(9), 1500-1505. [More Information]
van der Poorten, D., George, J. (2007). Current and novel therapies for the treatment of nonalcoholic steatohepatitis. Hepatology International, 1(3), 343-354. [More Information]
van der Poorten, D., Kenny, D., Butler, T., George, J. (2007). Liver disease in adolescents: A cohort study of high-risk individuals. Hepatology, 46(6), 1750-1758. [More Information]
van der Poorten, D., Katelaris, P. (2007). The effectiveness of rifabutin triple therapy for difficult-to-eradicate Helicobacter pylori in clinical practice. Alimentary Pharmacology and Therapeutics, 26(11), 1537-1542. [More Information]
van der Poorten, D., Kenny, D. (2007). Young offenders in custody and the community: Similarities and differences. 3rd International Congress of Psychology and Law, in conjunction with the 27th Annual Congress of ANZAPPL.

show 3 more

2006

van der Poorten, D., Kwok, A., Lam, T., Ridley, L., Jones, B., Ngu, M., Lee, A. (2006). Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital. Internal Medicine Journal, 36(11), 692-699. [More Information]

Faculty of Medicine and Health

Page not found

Associate Professor David van der Poorten

Publications

By Type

By Year